Causal associations between type 1 diabetes mellitus and cardiovascular diseases: a Mendelian randomization study.
Liu Z, Wang H, Yang Z, Lu Y, Zou C.
Cardiovasc Diabetol. 2023 Sep 2;22(1):236. doi: 10.1186/s12933-023-01974-6.
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial.
Petrie JR, Chaturvedi N, Ford I, Brouwers MCGJ, Greenlaw N, Tillin T, Hramiak I, Hughes AD, Jenkins AJ, Klein BEK, Klein R, Ooi TC, Rossing P, Stehouwer CDA, Sattar N, Colhoun HM; REMOVAL Study Group.
Lancet Diabetes Endocrinol. 2017 Aug;5(8):597-609. doi: 10.1016/S2213-8587(17)30194-8. Epub 2017 Jun 11.
Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.
LeRoith D, Biessels GJ, Braithwaite SS, Casanueva FF, Draznin B, Halter JB, Hirsch IB, McDonnell ME, Molitch ME, Murad MH, Sinclair AJ.
J Clin Endocrinol Metab. 2019 May 1;104(5):1520-1574. doi: 10.1210/jc.2019-00198.
Atherosclerosis: risk assessment and the role of aiming for optimal glycaemic control in young patients with type 1 diabetes.
Kolasa M, Olejnik A, Rusak E, Chobot A.
Pediatr Endocrinol Diabetes Metab. 2023;29(1):42-47. doi: 10.5114/pedm.2022.122546.
SGLT2i in Patients with Type 1 Diabetes: Benefits, Risks, and Preventive Strategies.
Ma Y, Zhao Q, Peng H, Nalisa DL, Shan P, Jiang H.
Front Biosci (Landmark Ed). 2023 May 22;28(5):98. doi: 10.31083/j.fbl2805098.
Omega-3 fatty acids supplementation improves early-stage diabetic nephropathy and subclinical atherosclerosis in pediatric patients with type 1 diabetes: A randomized controlled trial.
Elbarbary NS, Ismail EAR, Mohamed SA.
Clin Nutr. 2023 Dec;42(12):2372-2380. doi: 10.1016/j.clnu.2023.10.007. Epub 2023 Oct 13.
[Atherosclerosis in patients with type 1 diabetes].
Karásek D.
Vnitr Lek. 2020 Winter;65(12):775-782.
Atherosclerosis in Pediatric and Adolescent Type 1 Diabetes-A Case for Early Identification?
Bajpai A.
Indian J Pediatr. 2023 Mar;90(3):215-216. doi: 10.1007/s12098-022-04430-7. Epub 2022 Dec 31.
Lipid-lowering in diabetes: An update.
Chait A, Eckel RH, Vrablik M, Zambon A.
Atherosclerosis. 2024 Jul;394:117313. doi: 10.1016/j.atherosclerosis.2023.117313. Epub 2023 Oct 6.
Risk factors for pre-clinical atherosclerosis in adolescents with type 1 diabetes.
Morandi A, Piona C, Corradi M, Marigliano M, Giontella A, Orsi S, Emiliani F, Tagetti A, Marcon D, Fava C, Maffeis C.
Diabetes Res Clin Pract. 2023 Apr;198:110618. doi: 10.1016/j.diabres.2023.110618. Epub 2023 Mar 9.
